{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T12:17:49Z","timestamp":1779365869066,"version":"3.53.0"},"publisher-location":"Dordrecht","reference-count":86,"publisher":"Springer Netherlands","isbn-type":[{"value":"9789400754157","type":"print"},{"value":"9789400754164","type":"electronic"}],"license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-94-007-5416-4_15","type":"book-chapter","created":{"date-parts":[[2012,12,5]],"date-time":"2012-12-05T23:36:12Z","timestamp":1354750572000},"page":"353-388","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Modeling the Polyglutamine Aggregation Pathway in Huntington\u2019s Disease: From Basic Studies to Clinical Applications"],"prefix":"10.1007","author":[{"given":"Keizo","family":"Sugaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,6]]},"reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1212\/WNL.51.3.882","volume":"51","author":"Y Abe","year":"1995","unstructured":"Abe Y, Tanaka F, Matsumoto M, Doyu M, Hirayama M, Kachi T, Sobue G (1995) CAG repeat number correlates with the rate of brainstem and cerebellar atrophy in Machado-Joseph disease. Neurology 51:882\u2013884","journal-title":"Neurology"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/ng0893-398","volume":"4","author":"SE Andrew","year":"1993","unstructured":"Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, Adam S, Starr E, Squitieri F, Lin B, Kalchman MA, Graham RK, Hayden MR (1993) The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington\u2019s disease. Nat Genet 4:398\u2013403","journal-title":"Nat Genet"},{"key":"15_CR3","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/nature02998","volume":"431","author":"M Arrasate","year":"2004","unstructured":"Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431:805\u2013810","journal-title":"Nature"},{"key":"15_CR4","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1001\/archneur.1996.00550120105023","volume":"53","author":"EH Aylward","year":"1996","unstructured":"Aylward EH, Codori AM, Barta PE, Pearlson GD, Harris GJ, Brandt J (1996) Basal ganglia volume and proximity to onset in presymptomatic Huntington disease. Arch Neurol 53:1293\u20131296","journal-title":"Arch Neurol"},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/1531-8257(200005)15:3<552::AID-MDS1020>3.0.CO;2-P","volume":"15","author":"EH Aylward","year":"2000","unstructured":"Aylward EH, Codori AM, Rosenblatt A, Sherr M, Brandt J, Stine OC, Barta PE, Pearlson GD, Ross CA (2000) Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington\u2019s disease. Mov Disord 15:552\u2013560","journal-title":"Mov Disord"},{"key":"15_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1212\/01.WNL.0000132965.14653.D1","volume":"63","author":"EH Aylward","year":"2004","unstructured":"Aylward EH, Sparks BF, Field KM, Yallapragada V, Shpritz BD, Rosenblatt A, Brandt J, Gourley LM, Liang K, Zhou H, Margolis RL, Ross CA (2004) Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology 63:66\u201372","journal-title":"Neurology"},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"15400","DOI":"10.1073\/pnas.0501651102","volume":"102","author":"AM Bhattacharyya","year":"2005","unstructured":"Bhattacharyya AM, Thanker AK, Wetzel R (2005) Polyglutamine aggregation nucleation: thermodynamics of a highly unfavorable protein folding reaction. Proc Natl Acad Sci USA 102:15400\u201315405","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR9","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.jmb.2005.10.053","volume":"355","author":"A Bhattacharyya","year":"2006","unstructured":"Bhattacharyya A, Thakur AK, Chellgren VM, Thiagarajan G, Williams AD, Chellgren BW, Creamer TP, Wetzel R (2006) Oligoproline effects on polyglutamine conformation and aggregation. J Mol Biol 355:524\u2013535","journal-title":"J Mol Biol"},{"key":"15_CR10","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1002\/mds.22601","volume":"24","author":"KM Biglan","year":"2009","unstructured":"Biglan KM, Ross CA, Langbehn DR, Aylward EH, Stout JC, Queller S, Carlozzi NE, Duff K, Beglinger LJ, Paulsen JS, PREDICT-HD Investigators of the Huntington Study Group (2009) Motor abnormalities in premanifest persons with Huntington\u2019s disease: the PREDICT-HD study. Mov Disord 24:1763\u20131772","journal-title":"Mov Disord"},{"key":"15_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/416507a","volume":"416","author":"M Bucciantini","year":"2002","unstructured":"Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddel N, Ramponi G, Dobson CM, Stefani M (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416:507\u2013511","journal-title":"Nature"},{"key":"15_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1006\/jmbi.2001.4850","volume":"311","author":"S Chen","year":"2001","unstructured":"Chen S, Berthelier V, Yang W, Wetzel R (2001) Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. J Mol Biol 311:173\u2013182","journal-title":"J Mol Biol"},{"key":"15_CR13","doi-asserted-by":"publisher","first-page":"11884","DOI":"10.1073\/pnas.182276099","volume":"99","author":"S Chen","year":"2002","unstructured":"Chen S, Ferrone FA, Wetzel R (2002) Huntington\u2019s disease age-of-onset linked to polyglutamine aggregation nucleation. Proc Natl Acad Sci USA 99:11884\u201311889","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/35018098","volume":"406","author":"G Clarke","year":"2000","unstructured":"Clarke G, Collins RA, Leavitt BR, Andrews DF, Hayden MR, Lumsden CJ, Mcinnes RR (2000) A one-hit model of cell death in inherited neuronal degeneration. Nature 406:195\u2013199","journal-title":"Nature"},{"key":"15_CR15","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1093\/hmg\/10.20.2269","volume":"10","author":"G Clarke","year":"2001","unstructured":"Clarke G, Lumsden CJ, Mcinnes RR (2001) Inherited neurodegenerative diseases: the one-hit model of neurodegeneration. Hum Mol Genet 10:2269\u20132275","journal-title":"Hum Mol Genet"},{"key":"15_CR16","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jtbi.2004.10.028","volume":"233","author":"G Clarke","year":"2005","unstructured":"Clarke G, Lumsden CJ (2005) Scale-free neurodegeneration: cellular heterogeneity and the stretched exponential kinetics of cell death. J Theor Biol 233:515\u2013525","journal-title":"J Theor Biol"},{"key":"15_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nchembio792","volume":"2","author":"DW Colby","year":"2006","unstructured":"Colby DW, Cassady JP, Lin GC, Ingram VM, Wittrup KD (2006) Stochastic kinetics of intracellular huntingtin aggregate formation. Nat Chem Biol 2:319\u2013323","journal-title":"Nat Chem Biol"},{"key":"15_CR18","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1126\/science.7901908","volume":"262","author":"JT Coyle","year":"1993","unstructured":"Coyle JT, Putfarken P (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689\u2013695","journal-title":"Science"},{"issue":"Suppl 1","key":"15_CR19","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/1471-2091-8-S1-S2","volume":"8","author":"JE Davies","year":"2007","unstructured":"Davies JE, Sarkar S, Rubinsztein DC (2007) The ubiquitin proteasome system in Huntington\u2019s disease and the spinocerebellar ataxias. BMC Biochem 8(Suppl 1):S2","journal-title":"BMC Biochem"},{"key":"15_CR20","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","volume":"90","author":"SW Davies","year":"1997","unstructured":"Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90:537\u2013548","journal-title":"Cell"},{"key":"15_CR21","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.biopsych.2006.11.034","volume":"62","author":"K Duff","year":"2007","unstructured":"Duff K, Paulsen JS, Beglinger LJ, Langbehn DR, Stout JC (2007) Psychiatric symptoms in Huntington\u2019s disease before diagnosis: the predict-HD study. Biol Psychiatry 62:1341\u20131346","journal-title":"Biol Psychiatry"},{"key":"15_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1176\/appi.neuropsych.22.2.196","volume":"22","author":"K Duff","year":"2010","unstructured":"Duff K, Paulsen JS, Beglinger LJ, Langbehn DR, Wang C, Stout JC, Ross CA, Aylward E, Carlozzi NE, Queller S, Predict-HD, Investigators of the Huntington Study Group (2010) \u201cFrontal\u201d behaviors before the diagnosis of Huntington\u2019s disease and their relationship to markers of disease progression: evidence of early lack of awareness. J Neuropsychiatry Clin Neurosci 22:196\u2013207","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"15_CR23","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S0076-6879(99)09019-9","volume":"309","author":"F Ferrone","year":"1999","unstructured":"Ferrone F (1999) Analysis of protein aggregation kinetics. Methods Enzymol 309:256\u2013274","journal-title":"Methods Enzymol"},{"key":"15_CR24","doi-asserted-by":"publisher","first-page":"16888","DOI":"10.1074\/jbc.M601470200","volume":"281","author":"AM Ellisdon","year":"2006","unstructured":"Ellisdon AM, Thomas B, Bottomley SP (2006) The two-stage pathway of ataxin-3 fibrillogenesis involves a polyglutamine-independent step. J Biol Chem 281:16888\u201316896","journal-title":"J Biol Chem"},{"key":"15_CR25","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nrg1691","volume":"6","author":"JR Gatchel","year":"2005","unstructured":"Gatchel JR, Zoghbi HY (2005) Disease of unstable repeat expansion: mechanisms and common principles. Nat Rev Genet 6:743\u2013755","journal-title":"Nat Rev Genet"},{"key":"15_CR26","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1126\/science.1124514","volume":"311","author":"T Gidalevitz","year":"2006","unstructured":"Gidalevitz T, Ben-Zvi AB, Ho KH, Brignull HR, Morimoto RI (2006) Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science 311:1471\u20131474","journal-title":"Science"},{"key":"15_CR27","first-page":"RE6","volume":"2003","author":"DA Gray","year":"2003","unstructured":"Gray DA, Tsirigotis M, Woulfe J (2003) Ubiquitin, proteasomes, and the aging brain. Sci Aging Knowledge Environ 2003:RE6","journal-title":"Sci Aging Knowledge Environ"},{"key":"15_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/35039051","volume":"1","author":"JF Gusella","year":"2000","unstructured":"Gusella JF, MacDonald ME (2000) Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease. Nat Rev Neurosci 1:109\u2013115","journal-title":"Nat Rev Neurosci"},{"key":"15_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid \u03b2-peptide. Nat Rev Mol Cell Biol 8:101\u2013112","journal-title":"Nat Rev Mol Cell Biol"},{"key":"15_CR30","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","volume":"67","author":"A Hershko","year":"1998","unstructured":"Hershko A, Ciechanover A (1998) The ubiquitin system. Annu Rev Biochem 67:425\u2013479","journal-title":"Annu Rev Biochem"},{"key":"15_CR31","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1001\/archneur.62.3.378","volume":"62","author":"R Hilker","year":"2005","unstructured":"Hilker R, Schweitzer K, Coburger S, Ghaemi M, Weisenbach S, Jacobs AH, Rudolf J, Herholz K, Heiss WD (2005) Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. Arch Neurol 62:378\u2013382","journal-title":"Arch Neurol"},{"key":"15_CR32","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3174\/ajnr.A2018","volume":"31","author":"NZ Hobbs","year":"2010","unstructured":"Hobbs NZ, Barnes J, Frost C, Henley SMD, Wild EJ, Macdonald K, Barker RA, Scahill RJ, Fox NC, Tabrizi SJ (2010) Onset and progression of pathologic atrophy in Huntington disease: a longitudinal MR imaging study. Am J Neuroradiol 31:1036\u20131041","journal-title":"Am J Neuroradiol"},{"key":"15_CR33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/79162","volume":"26","author":"DP Huynh","year":"2000","unstructured":"Huynh DP, Figueroa K, Hoang N, Pulst SM (2000) Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human. Nat Genet 26:44\u201350","journal-title":"Nat Genet"},{"key":"15_CR34","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0896-6273(02)00834-6","volume":"35","author":"M Katsuno","year":"2002","unstructured":"Katsuno M, Adachi H, Kume A, Li M, Nakagomi Y, Niwa H, Sang C, Kobayashi Y, Doyu M, Sobue G (2002) Teststerone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 35:843\u2013854","journal-title":"Neuron"},{"key":"15_CR35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ng1194-221","volume":"8","author":"Y Kawaguchi","year":"1994","unstructured":"Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S, Kawakami H, Nakamura S, Nishimura M, Akiguchi I, Kimura J, Narumiya S, Kakizuka A (1994) CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet 8:221\u2013228","journal-title":"Nat Genet"},{"key":"15_CR36","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486\u2013489","journal-title":"Science"},{"key":"15_CR37","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1523\/JNEUROSCI.19-03-00964.1999","volume":"19","author":"M Kim","year":"1999","unstructured":"Kim M, Lee HS, LaForet G, McIntyre C, Martin EJ, Chang P, Kim TW, Williams M, Reddy PH, Tagle D, Boyce FM, Won L, Heller A, Aronin N, DiFiglia M (1999) Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition. J Neurosci 19:964\u2013973","journal-title":"J Neurosci"},{"key":"15_CR38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0092-8674(00)81781-X","volume":"95","author":"IA Klement","year":"1998","unstructured":"Klement IA, Skinner PJ, Kaytor MD, Yi H, Hersch SM, Clark HB, Zoghbi HY, Orr HT (1998) Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95:41\u201353","journal-title":"Cell"},{"key":"15_CR39","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ajmg.b.30992","volume":"153B","author":"DR Langbehn","year":"2010","unstructured":"Langbehn DR, Hayden MR, Paulsen JS (2010) PREDICTHDInvestigators of the Huntington Study Group. CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches. Am J Med Genet B Neuropsychiatr Genet 153B:397\u2013408","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"15_CR40","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0896-6273(01)00422-6","volume":"31","author":"AR La Spada","year":"2001","unstructured":"La Spada AR, Fu YH, Sopher BI, Libby RT, Wang X, Li LY, Einum DD, Huang J, Possin DE, Smith AC, Martinez RA, Koszdin KL, Treuting PM, Ware CB, Hurley JB, Ptacek LJ, Chen S (2001) Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7. Neuron 31:913\u2013927","journal-title":"Neuron"},{"key":"15_CR41","doi-asserted-by":"publisher","first-page":"14777","DOI":"10.1074\/jbc.M109.093708","volume":"285","author":"J Legleiter","year":"2010","unstructured":"Legleiter J, Mitchell E, Lotz GP, Sapp E, Ng C, DiFiglia M, Thompson LM, Muchowski PJ (2010) Mutant huntingtin fragments form oligomers in a polyglutamine length-dependent manner in vitro and in vivo. J Biol Chem 285:14777\u201314790","journal-title":"J Biol Chem"},{"key":"15_CR42","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1074\/jbc.M609972200","volume":"282","author":"M Li","year":"2007","unstructured":"Li M, Chevalier-Larsen ES, Merry DE, Diamond MI (2007) Soluble androgen receptor oligomers underlie pathology in a mouse model of spinobulbar muscular atrophy. J Biol Chem 282:3157\u20133164","journal-title":"J Biol Chem"},{"key":"15_CR43","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-1-4615-1249-3_14","volume":"487","author":"J Lowe","year":"2001","unstructured":"Lowe J, Mayer J, Landon M, Layfield R (2001) Ubiquitin and the molecular pathology of neurodegenerative diseases. Adv Exp Med Biol 487:169\u2013186","journal-title":"Adv Exp Med Biol"},{"key":"15_CR44","first-page":"54","volume":"57","author":"P Maciel","year":"1995","unstructured":"Maciel P, Gaspar C, DeStefano AL, Silveira I, Coutinho P, Radvany J, Dawson DM, Sudarsky L, Guimaraes J, Loureiro JEL, Nezarati MM, Corwin LI, Lopes-Cendes I, Rooke K, Rosenberg R, MacLeod P, Farrer LA, Sequeiros J, Rouleau GA (1995) Correlation between CAG repeat length and clinical features in Machado-Joseph disease. Am J Hum Genet 57:54\u201361","journal-title":"Am J Hum Genet"},{"key":"15_CR45","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/ng0298-150","volume":"18","author":"D Martindale","year":"1998","unstructured":"Martindale D, Hackam A, Wieczorek A, Ellerby L, Wellington C, McCutcheon K, Singaraja R, Kazemi-Esfarjani P, Devon R, Kim SU, Bredesen DE, Tufaro F, Hayden MR (1998) Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nat Genet 18:150\u2013154","journal-title":"Nat Genet"},{"key":"15_CR46","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/hmg\/4.5.807","volume":"4","author":"H, Maruyama","year":"1995","unstructured":"Maruyama H, Nakamura S, Matsuyama Z, Sakai T, Doyu M, Sobue G, Seto M, Tsujihata M, Oh-i T, Nishino T, Sunohara N, Takahashi R, Hayashi M, Nishino I, Ohtake T, Oda T, Nishimura M, Saida T, Matsumoto H, Baba M, Kawaguchi Y, Kakizuka A, Kawakami H (1995) Molecular features of the CAG repeats and clinical manifestation of Machado-Joseph disease. Hum Mol Genet 4:807\u2013812","journal-title":"Hum Mol Genet"},{"key":"15_CR47","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.jmb.2004.09.065","volume":"344","author":"L Masino","year":"2004","unstructured":"Masino L, Nicastro G, Menon RP, Dal Piaz F, Calder L, Pastore A (2004) Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3. J Mol Biol 344:1021\u20131035","journal-title":"J Mol Biol"},{"key":"15_CR48","doi-asserted-by":"publisher","first-page":"10541","DOI":"10.1523\/JNEUROSCI.0146-10.2010","volume":"30","author":"J Miller","year":"2010","unstructured":"Miller J, Arrasate M, Shaby BA, Mitra S, Masliah E, Finkbeiner S (2010) Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into Huntington\u2019s disease molecular pathogenesis. J Neurosci 30:10541\u201310550","journal-title":"J Neurosci"},{"key":"15_CR49","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1074\/jbc.M806269200","volume":"284","author":"S Mitra","year":"2009","unstructured":"Mitra S, Tsvetkov AS, Finkbeiner S (2009) Single neuron ubiquitin-proteasome dynamics accompanying inclusion body formation in huntington disease. J Biol Chem 284:4398\u20134403","journal-title":"J Biol Chem"},{"key":"15_CR50","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.molmed.2004.12.002","volume":"11","author":"G Morfini","year":"2005","unstructured":"Morfini G, Pigino G, Brady ST (2005) Polyglutamine expansion diseases: failing to deliver. Trends Mol Med 11:64\u201370","journal-title":"Trends Mol Med"},{"key":"15_CR51","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1172\/JCI45364","volume":"121","author":"I Munoz-Sanjuan","year":"2011","unstructured":"Munoz-Sanjuan I, Bates GP (2011) The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease. J Clin Invet 121:476\u2013483","journal-title":"J Clin Invet"},{"key":"15_CR53","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nsmb1215","volume":"14","author":"Y Nagai","year":"2007","unstructured":"Nagai Y, Inui T, Popiel HA, Fujikake N, Hasegawa K, Urade Y, Goto Y, Naiki H, Toda T (2007) A toxic monomeric conformer of the polyglutamine protein. Nat Struct Mol Biol 14:332\u2013340","journal-title":"Nat Struct Mol Biol"},{"key":"15_CR54","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1093\/brain\/awp209","volume":"132","author":"R Nandhagopal","year":"2009","unstructured":"Nandhagopal R, Kuramoto L, Schulzer M, Mak E, Cragg J, Lee CS, Mckenzie J, McCormick S, Samii A, Troiano A, Ruth TJ, Sossi V, Fuente-Fernandez R, Calne DB, Stoessl AJ (2009) Longitudinal progression of sporadic Parkinson\u2019s disease: a multi-tracer positron emission tomography study. Brain 132:2970\u20132979","journal-title":"Brain"},{"key":"15_CR55","doi-asserted-by":"publisher","first-page":"9679","DOI":"10.1073\/pnas.0812083106","volume":"106","author":"Y Nekooki-Machida","year":"2009","unstructured":"Nekooki-Machida Y, Kurosawa M, Nukina N, Ito K, Oda T, Tanaka M (2009) Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity. Proc Natl Acad Sci USA 106:9679\u20139684","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR56","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1126\/science.1056784","volume":"291","author":"FC Nucifora","year":"2001","unstructured":"Nucifora FC Jr, Sasaki M, Peters MF, Huang H, Cooper JK, Yamada M, Takahashi H, Tsuji S, Troncoso J, Dawson VL, Dawson TM, Ross CA (2001) Interference by huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity. Science 291:2423\u20132428","journal-title":"Science"},{"key":"15_CR58","doi-asserted-by":"publisher","first-page":"21807","DOI":"10.1074\/jbc.M109.084434","volume":"285","author":"MA Olshina","year":"2010","unstructured":"Olshina MA, Angley LM, Ramdzan YM, Tang J, Bailey MF, Hill AF, Hatters DM (2010) Tracking mutant huntingtin aggregation kinetics in cells reveals three major populations that include an invariant oligomer pool. J Biol Chem 285:21807\u201321816","journal-title":"J Biol Chem"},{"key":"15_CR59","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0076-6879(06)13003-7","volume":"413","author":"B O\u2019Nuallain","year":"2006","unstructured":"O\u2019Nuallain B, Thanker AK, Williams AD, Bhattacharyya AM, Chen S, Thiagarajan G, Wetzel R (2006) Kinetics and thermodynamics of amyloid assembly using a high-performance liquid chromatography-based sedimentation assay. Methods Enzymol 413:34\u201374","journal-title":"Methods Enzymol"},{"key":"15_CR60","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0022-2836(62)80112-0","volume":"4","author":"F Oosawa","year":"1962","unstructured":"Oosawa F, Kasai M (1962) A theory of linear and helical aggregations of macromolecules. J Mol Biol 4:10\u201321","journal-title":"J Mol Biol"},{"key":"15_CR61","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1007\/s00018-007-7222-8","volume":"64","author":"Z Ortega","year":"2007","unstructured":"Ortega Z, Diaz-Hernandez M, Lucas JJ (2007) Is the ubiquitin-proteasome system impaired in Huntington\u2019s disease? Cell Mol Life Sci 64:2245\u20132257","journal-title":"Cell Mol Life Sci"},{"key":"15_CR62","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1093\/hmg\/10.20.2307","volume":"10","author":"HT Orr","year":"2001","unstructured":"Orr HT, Zoghbi HY (2001) SCA1 molecular genetics: a history of a 13 year collaboration against glutamines. Hum Mol Genet 10:2307\u20132311","journal-title":"Hum Mol Genet"},{"key":"15_CR63","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0076-6879(06)12008-X","volume":"412","author":"AP Osmand","year":"2006","unstructured":"Osmand AP, Berthelier V, Wetzel R (2006) Imaging polyglutamine deposits in brain tissue. Methods Enzymol 412:106\u2013122","journal-title":"Methods Enzymol"},{"key":"15_CR64","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1055\/s-2007-971172","volume":"27","author":"HL Paulson","year":"2007","unstructured":"Paulson HL (2007) Dominantly inherited ataxias: lessons learned from Machado-Joseph disease\/spinocerebellar ataxia type 3. Semin Neurol 27:133\u2013142","journal-title":"Semin Neurol"},{"key":"15_CR65","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/35084141","volume":"412","author":"MF Perutz","year":"2001","unstructured":"Perutz MF, Windle AH (2001) Cause of neural death in neurodegenerative diseases attributable to expansion of glutamine repeats. Nature 412:143\u2013144","journal-title":"Nature"},{"key":"15_CR66","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1073\/pnas.042681399","volume":"99","author":"MF Perutz","year":"2002","unstructured":"Perutz MF, Finch JT, Berriman J, Lesk A (2002) Amyloid fibers are water-filled nanotubes. Proc Natl Acad Sci USA 99:5591\u20135595","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR67","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/ana.410440424","volume":"44","author":"A Rosenblatt","year":"1998","unstructured":"Rosenblatt A, Margolis RL, Becher MW, Aylward E, Franz ML, Sherr M, Abbott MH, Lian KY, Ross CA (1998) Does CAG repeat number predict the rate of pathological changes in Huntington\u2019s disease? Ann Neurol 44:708\u2013709","journal-title":"Ann Neurol"},{"key":"15_CR68","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1212\/01.wnl.0000204230.16619.d9","volume":"66","author":"A Rosenblatt","year":"2006","unstructured":"Rosenblatt A, Liang, K-Y, Zhou H, Abbott MH, Gourley LM, Margolis RL, Brandt J, Ross CA (2006) The association of CAG repeat length with clinical progression in Huntington disease. Neurology 66:1016\u20131020","journal-title":"Neurology"},{"key":"15_CR69","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0896-6273(00)80405-5","volume":"19","author":"CA Ross","year":"1997","unstructured":"Ross CA (1997) Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron 19:1147\u20131150","journal-title":"Neuron"},{"key":"15_CR70","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0896-6273(02)00872-3","volume":"35","author":"CA Ross","year":"2002","unstructured":"Ross CA (2002) Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington\u2019s disease and related disorders. Neuron 35:819\u2013822","journal-title":"Neuron"},{"key":"15_CR71","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/nm1066","volume":"10","author":"CA Ross","year":"2004","unstructured":"Ross CA, Poirier MA (2004) Protein aggregation and neurodegenerative disease. Nat Med 10:10\u201317","journal-title":"Nat Med"},{"key":"15_CR72","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/jnnp.2007.116244","volume":"79","author":"HH Ruocco","year":"2008","unstructured":"Ruocco HH, Bonilha L, Li LM, Lopes-Cendes I, Cendes F (2008) Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat. J Neurol Neurosurg Psychiatry 79:130\u2013135","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"15_CR73","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","volume":"95","author":"F Saudou","year":"1998","unstructured":"Saudou F, Finkbeiner S, Devys D, Greenberg ME (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusion. Cell 95:55\u201366","journal-title":"Cell"},{"key":"15_CR74","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/protein\/gzp033","volume":"22","author":"HM Saunders","year":"2009","unstructured":"Saunders HM, Bottomley SP (2009) Multi-domain misfolding: understanding the aggregation pathway of polyglutamine proteins. Protein Eng Des Sel 22:447\u2013451","journal-title":"Protein Eng Des Sel"},{"key":"15_CR75","first-page":"1694","volume":"45","author":"J Schwarz","year":"2004","unstructured":"Schwarz J, Storch A, Koch W, Pogarell O, Radau PE, Tatsch K (2004) Loss of dopamine transporter binding in Parkinson\u2019s disease follows a single exponential rather than linear decline. J Nucl Med 45:1694\u20131697","journal-title":"J Nucl Med"},{"key":"15_CR76","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0925-4439(00)00040-5","volume":"1502","author":"MA Smith","year":"2000","unstructured":"Smith MA, Rottkamp CA, Nunomura A, Raina AK, Perry G (2000) Oxidative stress in Alzheimer\u2019s disease. Biochim Biophys Acta 1502:139\u2013144","journal-title":"Biochim Biophys Acta"},{"key":"15_CR77","doi-asserted-by":"publisher","first-page":"e635","DOI":"10.1371\/journal.pone.0000635","volume":"2","author":"K Sugaya","year":"2007","unstructured":"Sugaya K, Matsubara S, Kagamihara Y, Kawata A, Hayashi H (2007) Polyglutamine expansion mutation yield a pathological epitope linked to nucleation of protein aggregate: determinant of Huntington\u2019s disease onset. PLoS ONE 2:e635","journal-title":"PLoS ONE"},{"key":"15_CR78","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1186\/1750-1326-4-29","volume":"4","author":"K Sugaya","year":"2009","unstructured":"Sugaya K, Matsubara S (2009) Nucleation of protein aggregation kinetics as a basis for genotype-phenotype correlations in polyglutamine diseases. Mol Neurodegener 4:e29","journal-title":"Mol Neurodegener"},{"key":"15_CR89","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1186\/1750-1326-7-20","volume":"7","author":"K Sugaya","year":"2012","unstructured":"Sugaya K, Matsubara S (2012) Quantitative connection between polyglutamine aggregation kinetics and neurodegenerative process in patients with Huntington\u2019s disease. Mol Neurodegener 7:e20","journal-title":"Mol Neurodegener"},{"key":"15_CR79","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/0022-2836(88)90624-9","volume":"199","author":"A Szabo","year":"1988","unstructured":"Szabo A (1988) Fluctuations in the polymerization of sickle hemoglobin: A simple analytic model. J Mol Biol 199:539\u2013542","journal-title":"J Mol Biol"},{"key":"15_CR80","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/hmg\/ddm311","volume":"17","author":"T Takahashi","year":"2008","unstructured":"Takahashi T, Kikuchi S, Katada S, Nagai Y, Nishizawa M, Onodera O (2008) Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic. Hum Mol Genet 17:345\u2013356","journal-title":"Hum Mol Genet"},{"key":"15_CR81","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/jmcb\/mjq005","volume":"2","author":"T Takahashi","year":"2010","unstructured":"Takahashi T, Katada S, Onodera O (2010) Polyglutamine diseases: where does toxicity come from? What is toxicity? Where are we going? J Mol Cell Biol 2:180\u2013191","journal-title":"J Mol Cell Biol"},{"key":"15_CR82","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0896-6273(02)00875-9","volume":"35","author":"K Takeyama","year":"2002","unstructured":"Takeyama K, Ito S, Yamamoto A, Tanimoto H, Furutani T, Kanuka H, Miura M, Tabata T, Kato S (2002) Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in drosophila. Neuron 35:855\u2013864","journal-title":"Neuron"},{"key":"15_CR83","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1111\/j.1742-4658.2010.07721.x","volume":"277","author":"VM Uversky","year":"2010","unstructured":"Uversky VM (2010) Mysterious oligomerization of the amyloidogenic proteins. FEBS J 277:2940\u20132953","journal-title":"FEBS J"},{"key":"15_CR84","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/ana.20424","volume":"57","author":"BP van de Warrenburg","year":"2005","unstructured":"van de Warrenburg BP, Hendriks H, D\u00fcrr A, van Zuijelen MC, Stevanin G, Camuzat A, Sinke RJ, Brice A, Kremer BP (2005) Age at onset variance analysis in spinocerebellar ataxias: a study in Dutch-French cohort. Ann Neurol 57:505\u2013512","journal-title":"Ann Neurol"},{"key":"15_CR85","doi-asserted-by":"publisher","first-page":"11987","DOI":"10.1073\/pnas.0804350105","volume":"105","author":"K Watase","year":"2008","unstructured":"Watase K, Barrett CF, Miyazaki T, Ishiguro T, Ishikawa K, Hu Y, Unno T, Sun Y, Kasai S, Watanabe M, Gomez CM, Mizusawa H, Tsien RW, Zoghbi HY (2008) Spinocerebellar ataxia type 6 knock in mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant Cav2.1 channels. Proc Natl Acad Sci USA 105:11987\u201311992","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR86","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/nm0602-600","volume":"8","author":"J Xu","year":"2002","unstructured":"Xu J, Kao S-Y, Lee FJS, Song W, Jin L-W, Yankner BA (2002) Dopamine-dependent neurotoxicity of \u03b1-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat Med 8:600\u2013606","journal-title":"Nat Med"},{"key":"15_CR87","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/hmg\/11.8.905","volume":"11","author":"ZX Yu","year":"2002","unstructured":"Yu ZX, Li SH, Nguyen HP, Li XJ (2002) Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice. Hum Mol Genet 11:905\u2013914","journal-title":"Hum Mol Genet"},{"key":"15_CR88","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato C, Valenza M, Cattaneo E (2010) Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease. Physiol Rev 90:905\u2013981","journal-title":"Physiol Rev"}],"container-title":["Subcellular Biochemistry","Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-94-007-5416-4_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T11:19:50Z","timestamp":1675768790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-94-007-5416-4_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9789400754157","9789400754164"],"references-count":86,"URL":"https:\/\/doi.org\/10.1007\/978-94-007-5416-4_15","relation":{},"ISSN":["0306-0225"],"issn-type":[{"value":"0306-0225","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]},"assertion":[{"value":"6 December 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}